Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 2-8 (IGHD2-8) is one of several diversity gene segments located within the immunoglobulin heavy chain (IGH) locus on chromosome 14q32. During B cell development, the immune system generates high antibody diversity by somatically recombining variable (V), diversity (D), and joining (J) gene segments to form unique antibody receptor sequences. IGHD2-8 acts as a germline D-segment—one of the building blocks incorporated into the heavy chain variable region through V(D)J recombination, which is essential for the adaptive immune system's ability to recognize a vast array of antigens. IGHD segments themselves do not encode functional receptors or proteins; instead, their encoded sequence contributes to the final structure of immunoglobulin proteins following recombination in B lymphocytes. Key insights for structure: - IGHD2-8 is a gene segment (not a protein, enzyme, receptor, or biomarker). - It plays a structural and genetic role in antibody diversity but is not a direct disease gene or drug target. - This entry is not suitable for typical "therapeutic target" mapping. Most drug/biomarker information is null. - The canonical name and abbreviation provided are recognized in immunogenetics databases. - Alternative names ("DLR1", "IGHD28") arise from historical and database synonym conventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 2-8 (IGHD2-8).